STING1 and neoplasm: The combination of cGAMP canonical binding and PC7A polymer non-canonical binding results in synergistic STING activation and provides potent antitumor efficacy in multiple murine syngeneic tumor models, which was further enhanced by combination with the anti-PD1 checkpoint inhibitor [201].